Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Hobisch

Showing results (51-60 of 79) with videos related to

Pageof 8
Sort By:
International Journal of Oncology|July 31, 1998
Characterisation of a collecting duct carcinoma by cytogenetic analysis and comparative genomic hybridisationI Verdorfer, Z Culig, A Hobisch, et al.
Drugs & Aging|January 1, 1997
Androgen receptor gene mutations in prostate cancer. Implications for disease progression and therapyZ Culig, A Hobisch, A Hittmair, et al.
British Journal of Cancer|January 19, 2000
Androgen receptor protein is down-regulated by basic fibroblast growth factor in prostate cancer cellsM V Cronauer, C Nessler-Menardi, H Klocker, et al.
The Journal of Urology|March 21, 2001
Predictive value of total and percent free prostate specific antigen in high grade prostatic intraepithelial neoplasia lesions: results of the Tyrol Prostate Specific Antigen Screening ProjectW Horninger, H Volgger, H Rogatsch, et al.
The Journal of Pathology|July 6, 2000
Immunohistochemical localization of interleukin-6 and its receptor in benign, premalignant and malignant prostate tissueA Hobisch, H Rogatsch, A Hittmair, et al.
International Journal of Cancer|November 15, 1995
Mutant androgen receptors in prostatic tumors distinguish between amino-acid-sequence requirements for transactivation and ligand bindingH Peterziel, Z Culig, J Stober, et al.
International Journal of Oncology|November 20, 2001
Combined study of prostatic carcinoma by classical cytogenetic analysis and comparative genomic hybridizationI Verdorfer, A Hobisch, Z Culig, et al.
Histology and Histopathology|July 1, 1997
Hyperactive androgen receptor in prostate cancer: what does it mean for new therapy concepts?Z Culig, A Hobisch, A Hittmair, et al.
European Urology|January 1, 1995
Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor and epidermal growth factorZ Culig, A Hobisch, M V Cronauer, et al.
The Prostate|July 1, 1997
Synergistic activation of androgen receptor by androgen and luteinizing hormone-releasing hormone in prostatic carcinoma cellsZ Culig, A Hobisch, A Hittmair, et al.
Pageof 8

Showing results (51-60 of 79) with videos related to

Sort By:
Pageof 8
International Journal of Oncology|July 31, 1998
Characterisation of a collecting duct carcinoma by cytogenetic analysis and comparative genomic hybridisationI Verdorfer, Z Culig, A Hobisch, et al.
Drugs & Aging|January 1, 1997
Androgen receptor gene mutations in prostate cancer. Implications for disease progression and therapyZ Culig, A Hobisch, A Hittmair, et al.
British Journal of Cancer|January 19, 2000
Androgen receptor protein is down-regulated by basic fibroblast growth factor in prostate cancer cellsM V Cronauer, C Nessler-Menardi, H Klocker, et al.
The Journal of Urology|March 21, 2001
Predictive value of total and percent free prostate specific antigen in high grade prostatic intraepithelial neoplasia lesions: results of the Tyrol Prostate Specific Antigen Screening ProjectW Horninger, H Volgger, H Rogatsch, et al.
The Journal of Pathology|July 6, 2000
Immunohistochemical localization of interleukin-6 and its receptor in benign, premalignant and malignant prostate tissueA Hobisch, H Rogatsch, A Hittmair, et al.
International Journal of Cancer|November 15, 1995
Mutant androgen receptors in prostatic tumors distinguish between amino-acid-sequence requirements for transactivation and ligand bindingH Peterziel, Z Culig, J Stober, et al.
International Journal of Oncology|November 20, 2001
Combined study of prostatic carcinoma by classical cytogenetic analysis and comparative genomic hybridizationI Verdorfer, A Hobisch, Z Culig, et al.
Histology and Histopathology|July 1, 1997
Hyperactive androgen receptor in prostate cancer: what does it mean for new therapy concepts?Z Culig, A Hobisch, A Hittmair, et al.
European Urology|January 1, 1995
Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor and epidermal growth factorZ Culig, A Hobisch, M V Cronauer, et al.
The Prostate|July 1, 1997
Synergistic activation of androgen receptor by androgen and luteinizing hormone-releasing hormone in prostatic carcinoma cellsZ Culig, A Hobisch, A Hittmair, et al.
Pageof 8